Host: |
Rabbit |
Applications: |
WB/IHC-P/IF/ICC/ELISA |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Clonality: |
Monoclonal |
Clone ID: |
SRM |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.05% Proclin300, 0.05% BSA, 50% Glycerol, pH 7.3. |
Purification: |
Affinity purification |
Concentration: |
Lot specific |
Dilution Range: |
WB:1:500-1:1000IHC-P:1:500-1:1000IF/ICC:1:50-1:200ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
Gene Symbol: |
Cd8aCD8A |
Gene ID: |
12525925 |
Uniprot ID: |
CD8A_MOUSECD8A_HUMAN |
Immunogen Region: |
22-182 aa |
Specificity: |
Recombinant fusion protein containing a sequence corresponding to amino acids 22-182 of human CD8A (NP_001759.3). |
Immunogen Sequence: |
SQFRVSPLDRTWNLGETVEL KCQVLLSNPTSGCSWLFQPR GAAASPTFLLYLSQNKPKAA EGLDTQRFSGKRLGDTFVLT LSDFRRENEGYYFCSALSNS IMYFSHFVPVFLPAKPTTTP APRPPTPAPTIASQPLSLRP EACRPAAGGAVHTRGLDFAC D |
Tissue Specificity | P01731 - NAP01732 - CD8 on thymus-derived T-cells usually consists of a disulfide-linked alpha/CD8A and a beta/CD8B chain. Less frequently, CD8 can be expressed as a CD8A homodimer. A subset of natural killer cells, memory T-cells, intraepithelial lymphocytes, monocytes and dendritic cells expresses CD8A homodimers. Expressed at the cell surface of plasmacytoid dendritic cells upon herpes simplex virus-1 stimulation. |
Alternative Antibody Names | Anti-T-Cell Surface Glycoprotein Cd8 Alpha Chain antibodyAnti-T-Cell Surface Glycoprotein Lyt-2 antibodyAnti-Cd Antigen Cd8a antibodyAnti-Cd8a antibodyAnti-Lyt-2 antibodyAnti-Lyt2 antibodyAnti-T-Cell Surface Glycoprotein Cd8 Alpha Chain antibodyAnti-T-Lymphocyte Differentiation Antigen T8/Leu-2 antibodyAnti-Cd Antigen Cd8a antibodyAnti-CD8A antibodyAnti-MAL antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance